CDSCO now allows companies to begin lab testing of new drugs immediately after filing applications. The move aims to speed approvals for manufacturing or importing drugs while keeping technical scrutiny for later stages.
Alembic Pharma has received USFDA approval for its generic Lamotrigine Orally Disintegrating Tablets in multiple strengths, boosting its presence in the US generics market and expanding its epilepsy treatment portfolio.
GSK plc will acquire Canada-based 35Pharma for $950 million, adding HS235, a phase I-ready drug candidate for pulmonary hypertension, to strengthen its growing cardiopulmonary pipeline.
Alembic Pharmaceuticals has secured final approval from the FDA for its efinaconazole topical solution, a treatment for toenail fungal infections. This approval strengthens the company’s growing portfolio in the US market.
Indoco Remedies gets US FDA approval for its generic brivaracetam oral solution, 10 mg/mL, treating partial-onset seizures. Manufactured in Goa, it's a milestone for the company.
Eris Lifesciences has partnered with Natco Pharma to commercialize semaglutide in India, ahead of the patent expiry of the blockbuster diabetes and weight-loss drug ingredient. The launch is expected in March 2026.
Dr. Reddy’s Laboratories Ltd. has secured USFDA review for its proposed interchangeable abatacept biosimilar, DRL_AB, positioning itself as the first to file a BLA in this segment and strengthening its biologics footprint in the US market.
GSK has secured European Commission approval for Exdensur (depemokimab), a twice-yearly treatment for severe asthma and chronic rhinosinusitis with nasal polyps, offering sustained control for patients with uncontrolled type 2 inflammation.
Dr Reddy’s Laboratories has acquired the India trademarks of two hormone replacement therapy drugs from Mercury Pharma for $32.15 million, strengthening its women’s health portfolio and marking its entry into the growing HRT segment.
Eli Lilly is establishing India as a strategic center point in its global supply chain, with the assistance of the robust contract manufacturing ecosystem